SABR (stereotactic ablative body radiotherapy)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SABR (stereotactic ablative body radiotherapy), covering 2025-12-19 to 2025-12-19. Get the full timeline:
Most recent: Clinical Trial Update: RAdium-223 and SABR Versus SABR for Oligometastatic Prostate Cancers [Phase 2]